Qin XH, Tao Y, Zhang ZZ. Retinal astrocytic hamartoma in tuberous sclerosis complex in an elderly person: A case report. BMC ophthalmology, 2018, 18(1): 319. DOI: 10.1186/s12886- 018-0991-z.
[2]
Yui K, Imataka G, Sasaki H, et al. Improvement in impaired social cognition but not seizures by everolimus in a child with tuberous sclerosis-associated autism through increased serum antioxidant proteins and oxidant/antioxidant status. Case reports in pediatrics, 2019, 2019: 2070619.DOI: 10.1155/2019/2070619.
[3]
Wang F, Xiong S, Wu L, et al. A novel TSC2 missense variant associated with a variable phenotype of tuberous sclerosis complex: Case report of a Chinese family. BMC medical genetics, 2018, 19(1): 90. DOI: 10.1186/1687-9856-2014-23.
[4]
Mishra C, Kannan NB, Ramasamy K, et al. Retinal astrocytic hamartoma in tuberous sclerosis. Indian dermatol online J, 2019, 10(6): 753-754. DOI: 10.4103/idoj.IDOJ_23_19.
[5]
Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatric neurology, 2013, 49(4): 243-254. DOI: 10.1016/j.pediatrneurol. 2013.08.001.
[6]
Yan S, Chen Y, Chen R, et al. Subthreshold micropulse laser photocoagulation therapy in a case of bilateral retinal astrocytic hamartomas with tuberous sclerosis complex: A case report. Medicine, 2018, 97(50): e13265. DOI: 10.1097/ MD.0000000000013265.
Salazar-Quinones L, Arcos-Villegas G, Valverde-Megias A, et al. Vitreous haemorrhage a rare manifestation of retinal astrocytic hamartoma: A paediatric case report. Archivos de la Sociedad Espanola de Oftalmologia, 2019, 94(9): 449-452. DOI: 10.1016/ j.oftale.2019.04.009.
[9]
Choi JH, Jo HS, Lim S, et al. mTORC1 accelerates retinal development via the immunoproteasome. Nature communications, 2018, 9(1): 2502. DOI: 10.1038/s41467-018- 04774-9.